🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

24 recruiting trials

for Acute Migraine

A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India NCT07685769Phase 47 sites📍 Visakhapatnam📍 Gurugram📍 Bangalore Pfizer · Tests: Rimegepant 75 mg ODT Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals NCT07022496Phase 41 site📍 Cairo Ain Shams University · Tests: Caffeine (200 mg), triptans, NSAID (Nonsteroidal anti-inflammatory drugs), Paracetamol (acetaminophen) Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults NCT07792681Phase 2, Phase 383 sites📍 Shanxi📍 Inner Mongolia📍 Beijing Brise Pharmaceuticals Co., Ltd. · Tests: BR005-036C, BR005-036C, Placebo Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA NCT05754190n/a1 site📍 Providence Brown University · Tests: SOMA pain manager smartphone application A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine NCT07609914Phase 424 sites📍 Canoga Park📍 Fresno📍 Los Angeles Pfizer · Tests: Rimegepant i-NEED: NEw migrainE Drugs Database NCT07103694n/a2 sites📍 Milan📍 Rome IRCCS San Raffaele Roma · Tests: anti-CGRP monoclonal antibodies, gepants, combination of sumatriptan and naproxen, ditan A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine NCT06995729Phase 114 sites📍 Washington D.C.📍 Hinesville📍 Minneapolis Pfizer · Tests: Zavegepant Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain. NCT05780450NA2 sites📍 Paiporta📍 Valencia Fundación Universidad Católica de Valencia San Vicente Márt… · Tests: Transcranial Direct Current Therapy (tDCS), Sham (No Treatment) Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site📍 Delafield Brain Inflammation Collaborative Acute Treatment of Vestibular Migraine by Rimegepant NCT07871097Phase 41 site📍 Wuhan Wensheng Qu · Tests: First dose rimegepant, second dose placebo, First dose placebo, second dose rimegepant Gepant treAtments: EffectIveNess and tolERability (GAINER) NCT05903027n/a2 sites📍 Florence📍 Pavia University of Florence · Tests: Rimegepant 75 MG Disintegrating Oral Tablet Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks NCT07310290n/a3 sites📍 Aliso Viejo📍 Naperville📍 Grand Island AbbVie Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients NCT07646613Phase 220 sites📍 Phoenix📍 Lemon Grove📍 Walnut Creek Aspeya, Inc. · Tests: ASY202, Placebo Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) NCT05125302Phase 3129 sites📍 Huntsville📍 Saraland📍 Phoenix AbbVie · Tests: Ubrogepant, Placebo-Matching Ubrogepant Randomized Study in Children and Adolescents With Migraine: Acute Treatment NCT04649242Phase 3246 sites📍 Birmingham📍 Scottsdale📍 Tempe Pfizer · Tests: Rimegepant/BHV3000, Matching placebo Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine NCT04743141Phase 3124 sites📍 Scottsdale📍 Tempe📍 Anaheim Pfizer · Tests: Rimegepant (PF-07899801) Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults NCT07304518Phase 21 site📍 Beijing Sichuan Purity Pharmaceutical Technology Co., Ltd. · Tests: PRT-064040 nasal spray, Placebo A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine NCT07645924Phase 3113 sites📍 Birmingham📍 Mobile📍 Chandler Kallyope Inc. · Tests: Elismetrep, Placebo Carotid Sinus Massage in Trendelenburg Position for Headache Relief NCT06745648NA1 site📍 Trenque Lauquen Hospital Municipal Pedro T. Orellana · Tests: Arm A - Carotid Sinus Massage + Trendelenburg (CSM+T), Arm B - Sham CSM+T Efficacy of Nerve Blocks for Episodic Migraine NCT05734625Phase 21 site📍 Rochester Mayo Clinic · Tests: Bupivacaine HCl 0.5% Injectable Solution, Methylprednisolone 40 MG Injection A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine NCT07674654Phase 3113 sites📍 Birmingham📍 Mobile📍 Chandler Kallyope Inc. · Tests: Elismetrep A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine NCT07816367Phase 372 sites📍 Glendale📍 Phoenix📍 Phoenix Kallyope Inc. · Tests: Elismetrep, Placebo Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications NCT06401642Phase 41 site📍 Phoenix Mayo Clinic · Tests: Zavegepant High- vs Standard-Dose Intravenous Magnesium for Acute Headache NCT07779486NA1 site📍 Monastir University of Monastir · Tests: Magnesium Sulfate 2 grams, Magnesium Sulfate 4 G, Paracetamol 1 g
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy